It is of high interest that AGGF1 protein therapy inhibited cardiac hypertrophy and heart failure and restored myocardial function (LVEF and LVFS) to nearly normal levels by blocking ER stress-induced apoptosis (Figs. 3 and 4). This evidence concerns the gene AGGF1 and heart failure.